Clinical trial Recruiting at 1 site Interventional Ages 8 to 12

Dual-task exercises to improve movement and thinking in children with mild intellectual disability.

Official title: Effects of Different Dual-Task Exercises on Motor and Cognitive Functions in Children With Mild Mental Retardation

Run by Istanbul University - Cerrahpasa · NCT07028333 · Data updated 2026-11-12

This program will test whether motor-motor and motor-cognitive dual-task exercises help children ages 8–12 with mild intellectual disability improve mobility, balance, thinking, and quality of life.

Quick facts

Study typeInterventional
Ages8 Years to 12 Years
SexAll
Enrollment33 (estimated)
SponsorIstanbul University - Cerrahpasa
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedNovember 15, 2024
Main results expectedJuly 5, 2025
Study endsNovember 10, 2025
Registry record updatedJune 19, 2025
Trial IDNCT07028333 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 8–12 with a documented educational diagnosis of mild intellectual disability (IQ 51–70), parental consent, ability to understand Turkish instructions, and no additional disabilities that would prevent participation are ideal candidates.

Probably not a fit

Children with IQs outside the 51–70 range (moderate or severe intellectual disability), significant sensory or medical impairments, regular engagement in exercise, or other conditions that prevent compliance are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional program compares motor-motor dual-task training, motor-cognitive dual-task training, and a control condition in children with mild intellectual disability (IQ 51–70) aged 8–12. Participants complete supervised exercise sessions and are assessed before and after the intervention on functional mobility, balance, cognitive function, and quality of life. The motor-motor arm combines two physical tasks at once while the motor-cognitive arm pairs a physical task with a thinking task to challenge simultaneous processing. Group outcomes will be compared to determine which approach produces greater functional and cognitive gains.

Why it matters

Potential benefit: If successful, the program could improve children's mobility, balance, thinking skills, and overall quality of life, helping with daily activities and participation.

How similar studies have gone: Dual-task training has shown balance and mobility benefits in other groups, but evidence specifically targeting children with mild intellectual disability is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Obtaining parental consent
* Having an Intelligence Quotient between 51-70
* Having an educational diagnosis of mild mental retardation
* Being between the ages of 8-12
* Ability to understand Turkish instructions
* Ability to follow commands during the exercise program
* No additional disabilities that would prevent participation in the program

Exclusion Criteria:

* Having a metabolic or systemic disease
* Engaging in regular physical exercise
* Having visual or hearing impairments
* Presence of any condition that would interfere with compliance to assessment parameters

Where it's running

  • Istanbul University Cerrahpasa
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.